Exelixis Inc Dl 01 Stock Quote EX9 - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Germany
TG
Exelixis Inc Dl 01 (EX9) Quote

Exelixis Inc Dl 01 (EX9)

20.26

-0.11

(-0.54%)

Closed June 08 4:00PM

Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

20.26

Bid

19.91

Ask

20.62

Volume

21

20.48 Day's Range 20.63

17.45 52 Week Range 22.35

Market Cap

Previous Close

20.37

Open

20.63

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

377

Shares Outstanding

303,194,259

Dividend Yield

-

PE Ratio

31.93

Earnings Per Share (EPS)

0.69

Revenue

1.83B

Net Profit

207.77M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.exelixis.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Exelixis Inc Dl 01 is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker EX9. The last closing price for Exelixis Inc Dl 01 was 20.37 €. Over the last year, Exelixis Inc Dl 01 shares have traded in a share price range of 17.45 € to 22.35 €.

Exelixis Inc Dl 01 currently has 303,194,259 shares outstanding. The market capitalization of Exelixis Inc Dl 01 is 6.63 € billion. Exelixis Inc Dl 01 has a price to earnings ratio (PE ratio) of 31.93.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.21	1.04738154613	20.05	20.63	20	195	20.27079589	DE
4	0.19	0.946686596911	20.07	20.63	18.485	210	19.30024355	DE
12	-0.639999	-3.06219631877	20.899999	22.35	18.485	377	21.12190793	DE
26	0.180001	0.896419367352	20.079999	22.35	17.45	413	20.53474341	DE
52	-0.549999	-2.64295543695	20.809999	22.35	17.45	442	20.26230982	DE
156	1.68	9.04198062433	18.58	22.35	13.615	366	19.07812075	DE
260	5.28	35.2469959947	14.98	25.77	12.432	350	19.00851315	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CLEUChina Liberal Education Holdings Ltd	$ 3.1505 (55.97%)	18.32M
HUDAHudson Acquisition I Corporation	$ 16.6999 (52.51%)	636.05k
VEROVenus Concept Inc	$ 0.893101 (52.22%)	69.53M
HRYUHanryu Holdings Inc	$ 0.5047 (40.55%)	2.83M
HUDAUHudson Acquisition I Corporation	$ 15.77 (30.22%)	3.77k
DSYBig Tree Cloud Holdings Limited	1.9091 (-74.67%)	359.21k
BMEABiomea Fusion Inc	$ 4.14 (-63.27%)	11.22M
NBSTWNewbury Street Acquisition Corporation	$ 0.0374 (-32.00%)	174.15k
DHACUDigital Health Acquisition Corporation	$ 15.90 (-30.20%)	2.1k
SCNIScinai Immunotherapeutics Ltd	$ 2.97 (-28.41%)	706.54k
FFIEFaraday Future Intelligent Electric Inc	$ 0.602 (10.66%)	409.72M
PRSTPresto Technologies Inc	$ 0.09 (18.58%)	324.44M
CRKNCrown Electrokinetics Corporation	$ 0.0902 (3.20%)	117.32M
SQQQProShares UltraPro Short QQQ	$ 9.32 (0.32%)	116.71M
GERNGeron Corp	$ 4.60 (18.25%)	93.53M

frrol

frrol 5 minutes ago

Cambreau

Cambreau 5 minutes ago

New here ...Anyone in / familiar with RDGL ? Similar companies working on the same things ? They have 2X the OS of PPCB and are 100X pps at .17 I'll do more DD when time permits. TIA.

dragoon76

dragoon76 7 minutes ago

Moronius Simpletus

DewDiligence

DewDiligence 7 minutes ago

GSK/(PFE)/(MRNA)—FDA_lowers_youngest_age_for Arexvy to 50—(rather than 60):

https://www.businesswire.com/news/home/20240606055012/en The regulatory application was supported by positive results from a phase III trial (https://www.clinicaltrials.gov/study/NCT05590403 ) evaluating the

Polymer Paul

Polymer Paul 7 minutes ago

Some more positive news I can verify and is 100% accurate. The UK contingent are throwing skin back in the game starting Monday! They can virtually double their position since they left at $4.50.

DewDiligence

DewDiligence 8 minutes ago

GSK/(PFE)/(MRNA)—FDA_lowers_youngest_age_for Arexvy to 50—(rather than 60):

https://www.businesswire.com/news/home/20240606055012/en The regulatory application was supported by positive results from a phase III trial (https://www.clinicaltrials.gov/study/NCT05590403 ) evaluating the

Mr.Nurse

Mr.Nurse 9 minutes ago

Well. Not the best close for the week IMO. I guess know the levels. Make a plan. Stick with it. Change it. Just have one! Can't wait for profitability on the balance sheet!

frrol

frrol 10 minutes ago

Don't suffer fools.

Savannah-Marc

Savannah-Marc 12 minutes ago

Big Money Monday is upon us, see you @
https://www.forbes.com/billionaires/

newman2021

newman2021 12 minutes ago

I called my pharmacist. The rumor is we are getting the generic vascepa from Amarin starting July. This is a good move irrespective of the skinny label outcome of the court, imo

stock king 1

stock king 1 12 minutes ago

First order out $$$$$&&&&&&&$

stock king 1

stock king 1 12 minutes ago

First order out $$$$$&&&&&&&$

DKLN

DKLN 12 minutes ago

The pushers have been saying don't worry for years while posting irrelevant Youtube videos.Yet this stock still sits at a pathetic .0015 with poor volume after 5+ years. The lesson - when the pushers talk, ignore them, which is what potential investors do.

dcspka

dcspka 12 minutes ago

As I have mentioned before, at this point in time I am not looking for a Greater Fool to take a losing position off my hands. I simply want Dr. J to stop avoiding us and answer the questions he has refused to acknowledge. I trust people are at least intelligent to know when they have been shafted.

DewDiligence

DewDiligence 12 minutes ago

GSK/(PFE)/(MRNA)—FDA_lowers_youngest_age_for Arexvy to 50—(rather than 60):

https://www.businesswire.com/news/home/20240606055012/en The regulatory application was supported by positive results from a phase III trial (https://www.clinicaltrials.gov/study/NCT05590403 ) evaluating the

Grip it and Sip It

Grip it and Sip It 14 minutes ago

Yes or no? I called the pump and dump! The answer is yes.

Steady_T

Steady_T 14 minutes ago

I wanted to let the rest of Ihub see what messages you send. To let them see your excellence.

price_and_volume

price_and_volume 15 minutes ago

To be fair, its NOT "operating".
How in the world is VXIT operating?

...no cash, no revenues, no new financing... accounts payable rises every quarter since they pay no one. An insolvent Balance Sheet. It appears JK privately communicates with a handful of individual-shareholde

DesertDrifter

DesertDrifter 15 minutes ago

https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/447748292_3838018149815250_8547082312569207540_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=5f2048&_nc_ohc=6V4_LhPY9aMQ7kNvgFUn8W1&_nc_ht=scontent-lax3-1.xx&oh=00_AYDKsQZs1zAkyTRSJ3wPWWO4Uhp0oD2wlzDPRM2R2YsqjA&oe=666AA885

https://scontent-lax3-2

MirageRiver2

MirageRiver2 15 minutes ago

We hitting 1 dollar end of June (ADHD medicine getting approved) and 3 dollars in September (facility up and running 4x output) 5 dollars in march 2025 (Purdue pharma patent for OxyContin expires)

coop7

coop7 16 minutes ago

I have watched in the past and when you click properties on a website picture you get an answer where it came from. that is a simple ploy used to advertise just as done on a commercial website when some business's wish you to see a sample of something they do not possess or have control of. it's cal

gorbec1

gorbec1 17 minutes ago

https://youtu.be/f3bO8TKNMK8?si=6wIpNPSNg4LTYIPI

Exelixis Inc Dl 01

Taiyo Yuden (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions